Abstract
Male rats were screened for their response to a novel environment and designated as high responders (HRs) or low responders (LRs). They then received daily injections of saline or cocaine (20 mg/kg, i.p.). Basal and cocaine-evoked extracellular dopamine (DAext) levels as well as basal DA uptake rate and cocaine-evoked inhibition of uptake in the nucleus accumbens were determined on abstinence day 3 using quantitative microdialysis under transient conditions. The kinetics of uptake, dopamine transporter (DAT) expression, and [3H](−)-2-β-carbomethoxy-3-β-(4-fluorophenyl)tropane 1,5-naphthalenedisulfonate ([3H]WIN35428) binding were also examined. The locomotor activating effects of cocaine and the magnitude of behavioral sensitization were greater in HRs. Saline-treated HRs had lower basal uptake than LRs. DA uptake after cocaine challenge was also lower in these animals. Although basal DAext did not differ, cocaine-evoked DAext was greater in HRs. The Km andVmax of DA uptake were higher in naive HRs than LRs, as were the Kd andBmax of [3H]WIN35428 binding. DAT protein expression did not differ. Previous cocaine exposure decreased basal DA uptake. It increased cocaine-evoked DAext and decreased the cocaine-induced inhibition of uptake, especially in HRs, indicating greater DA release during cocaine challenge in this phenotype. We hypothesize that lower basal uptake in HRs results from a decrease in DAT binding affinity that is compensated for, in part, by an increased number of plasma membrane binding sites. Basal uptake, but not DAext, was lower in HRs, indicating lower basal DA release in HRs. The finding that cocaine-evoked DAext is higher in naive and cocaine-exposed HRs suggests that the greater responsiveness of DA neurons in HRs may underlie the enhanced behavioral responses that characterize this phenotype.
- individual differences in response to novelty
- dopamine
- dopamine uptake and release
- nucleus accumbens
- cocaine
- transient no net flux microdialysis
Introduction
One focus of addiction research is identification of the neural substrates underlying individual differences in vulnerability to develop compulsive drug-seeking behavior. The locomotor response to a novel environment is predictive of individual differences in the behavioral effects of psychostimulants (Piazza and Le Moal, 1996). High responders (HRs) exhibit greater locomotor activity in an open field, exhibit greater psychostimulant-induced activity, and have a greater propensity to acquire psychostimulant self-administration than individuals exhibiting less activity in an open field [low responders (LRs)] (Piazza et al., 1989).
The role of the mesocorticolimbic system in psychostimulant-induced behaviors has prompted hypotheses that differences in the activity of DA neurons projecting to the nucleus accumbens (NAc) may underlie these phenotypes. Indeed, NAc microinjections of a DA antagonist (Hooks and Kalivas, 1995) prevent novelty-induced locomotor activity, and HRs have a higher DOPAC/DA ratio in the NAc (Piazza et al., 1991). Microdialysis studies showed that, although basal DA levels do not differ, psychostimulant-induced increases in NAc DA are greater in HRs (Hooks et al., 1991b; Rouge-Pont et al., 1993). However, conclusions derived from postmortem studies are limited because extracellular concentrations cannot be determined. Furthermore, although no difference between HRs and LRs in basal dialysate DA levels was reported previously (Hooks et al., 1991b), dialysate levels not only do not permit quantification of extracellular levels, but changes in this parameter can result from changes in uptake and/or extracellular levels. Moreover, changes in DA uptake can alter the microdialysis probe extraction fraction (Ed), leading to overestimations or underestimations of extracellular levels (Justice, 1993; Shippenberg and Thompson, 1997).
No-net-flux microdialysis provides an estimate of basal extracellular dopamine (DAext) levels that is independent of Ed alterations. Using this technique, Hooks et al. (1992) reported that basal DAext, but not dialysate DA levels, were elevated in the NAc of HRs. Ed, an indirect measure of DA uptake, did not differ. This finding is surprising in view of reports (Shippenberg and Thompson, 1997; Shippenberg et al., 1999) that lack of concordance between the effects of a manipulation on dialysate and DAext levels results from altered uptake. Moreover, a recent chronoamperometry study (Sabeti et al., 2002) provided evidence that differences in DA transporter (DAT) function may reflect different addiction phenotypes. It is notable also that in the study by Hooks et al. (1992), Ed was determined before cocaine challenge, and this value was used to calculate DAext after cocaine challenge. Given the relationship between changes in DA uptake and Ed, and given that cocaine inhibits uptake, the failure to redetermine Ed after cocaine administration may have confounded measurement of DA dynamics.
Quantitative microdialysis under transient conditions (Olson and Justice, 1993) permits assessment of alterations in DAext and DA uptake as a function of time after drug administration. A between-group design, in which separate groups of animals are perfused with a single DA concentration, enables quantification of DAext and Ed at various times. Using this technique, we have characterized basal and cocaine-evoked NAc DA dynamics in naive HRs and LRs and those with a history of cocaine administration. DAT function and the kinetics of DA uptake were assessed in vitro.
Materials and Methods
Animals. Male Sprague Dawley rats (Charles River Laboratories, Wilmington, MA) weighing 250–300 gm were housed in groups of three per cage for at least 1 week before use. They were maintained in a temperature- and humidity-controlled environment under a 12 hr light/dark cycle with laboratory rat chow and water available ad libitum. All experiments were performed during the light cycle. Animals used in these studies were maintained in facilities accredited by the American Association for the Accreditation of Laboratory Animal Care, and all experiments were conducted in accordance with the guidelines of the Institutional Care and Use Committee of the National Institute on Drug Abuse (Rockville, MD), National Institutes of Health.
Selection of HRs and LRs to novelty. All animals were tested for their locomotor response to a novel environment 1 week before the commencement of the pretreatment regimens. Locomotor activity was measured in Plexiglas cages (43 × 44 × 25 cm) using an Opto-Varimex system (Columbus Instruments, Columbus, OH). The horizontal sensor of the system consisted of two arrays of 15 infrared beams, which were placed perpendicular to each other. The beams were spaced 2.4 cm apart. The Opto-Varimex was equipped with aColumbus Instruments data collection system and software package for an IBM computer (Auto-Track System V3.20A;Columbus Instruments). The location of an animal was read by the Auto-Track system 10 times each second. The distance traveled by each animal during a single 2 hr session was determined. Animals were designated as HRs or LRs depending on whether their activity was above or below the median value (Piazza et al., 1989, 1990). Rats were tested in groups of 16 animals. Four animals with values closest to the median were not used in the subsequent experiments.
Surgical procedures. Animals were anesthetized with Equithesin (3 ml/kg) and implanted unilaterally with a microdialysis guide cannula (CMA/11; CMA/Microdialysis, Acton, MA) aimed at the NAc using standard stereotaxic techniques. Each rat was mounted in a stereotaxic apparatus (David Kopf Instruments, Tujunga, CA) with the upper incisor bar set 3.5 mm below the interaural line. The coordinates (anterior, +1.7 relative to bregma; lateral, ±0.9; ventral, −6.0 from the dura surface) were based on the atlas ofPaxinos and Watson (1986). The microdialysis guide cannula and a head-mount screw, which permitted attachment of the animal to a spring tether, were cemented in place with dental acrylic and three stainless-steel screws.
Drug treatments. Equal numbers of animals were assigned to the cocaine and saline pretreatment groups. After 3–4 d of handling and recovery, rats received daily injections of either saline (1.0 ml/kg, i.p.) or cocaine (20 mg/kg, i.p.) in their home cages for 5 d. Cocaine hydrochloride was supplied by the Research Technology Branch of the National Institute on Drug Abuse and prepared in sterile saline.
Microdialysis procedures. Microdialysis experiments were conducted 3 d after the last cocaine or saline injection. A microdialysis probe (CMA/11; membrane dimension 0.24 × 2 mm) was manually inserted into the microdialysis guide cannula ∼12 hr before the commencement of the experiments. The inlet tubing of the probe was connected to a microinfusion pump (Instech syringe pump, model 2000, Instech, Plymouth Meeting, PA) via a dual quartz-lined swivel (Instech), and the animal was placed into a Plexiglas test chamber (40 × 40 × 35 cm). The microdialysis probe was flushed overnight at a flow rate of 0.3 μl/min with artificial CSF (aCSF), containing (in mm): 145 NaCl, 2.8 KCl, 1.2 MgCl2, 1.2 CaCl2, 0.25 ascorbic acid (to minimize oxidation of DA during no-net-flux experiments) and 5.4d-glucose, adjusted to pH 7.2 using NaOH or H3PO4 (HPLC grade). The aCSF was filtered through a 0.22 μm filter (Millipore Corp., Bedford, MA). Placing animals into the test chamber 12 hr before the experiment and overnight perfusion of probes with aCSF (at a flow rate of 0.3 μl/min) allowed animals to habituate to the microdialysis environment and the levels of DA to return to baseline after probe insertion. On the day of the experiment, perfusate was replaced with one of three different concentrations of DA in aCSF (DAin: 0, 10, or 40 nm). Samples were collected in microcentrifuge tubes every 10 min at a flow rate of 0.6 μl/min after a 50–60 min equilibration period.
Five consecutive samples were collected for the determination of basal levels of DAext and Ed. Animals were then injected with cocaine (20 mg/kg, i.p.), and samples were collected for another 50 min. Samples and DA standards were frozen on dry ice in 6 μl aliquots and then placed at −80°C until analyzed.
Evaluation of behavioral response to cocaine challenge. The behavioral effects produced by the acute challenge dose of cocaine were quantified using a modification of the behavioral rating scale ofEllinwood and Balster (1974) For each 5 min observational period, each animal was assigned a rating score from 1 to 9. The definition of each score was as follows: 1, asleep; 2, inactive, lying down, eyes open; 3, normal in-place activities (grooming, etc.); 4, moving about the cage, sniffing, rearing; 5, hyperactive, increased locomotor activity with rapid changes in position; 6, slow-patterned, repetitive explorations of the cage at normal level of activity; 7, fast-patterned, repetitive exploration with hyperactivity; 8, restricted, in-place repetitive behavior; 9, exaggerated in-place repetitive behavior, backing up, jumping.
Histology. After the completion of microdialysis experiments, all animals were deeply anesthetized with pentobarbital (>80 mg/kg, i.p.) and killed by decapitation. The brains were removed and frozen. Histological verification of the site of probe placement was obtained via coronal sections (20 μm thick) using a microtome (model 5030; Hacker Instruments, Fairfield, NJ). Representative sections were analyzed according to the atlas of Paxinos and Watson (1986). Only data obtained from animals with histologically correct placements were used for subsequent statistical analysis.
Chromatographic analysis of brain microdialysates. The samples and DA standards were thawed and placed in a CMA/200 refrigerated microsampler (CMA/Microdialysis) connected to an HPLC system with electrochemical detection. The separation and quantification of DA was achieved by using a microbore HPLC column (100 × 2 mm; C-18; 3 μm; MF-8957; Bioanalytical Systems, West Lafayette, IN) and an LC-4C amperometric detector (Bioanalytical Systems). The applied potential was set at 650 mV versus Ag/AgCl reference electrode. The mobile phase consisted of 0.15 mNaH2PO4, 1.7 mm sodium octyl sulfate, 1.0 mm EDTA, 12% methanol, and an apparent pH of 5.0. All reagents were analytical grade and were obtained from Sigma (St. Louis, MO) and Fluka BioChemica (Ronkonkoma, NY). The mobile phase was filtered through a 0.22 μm filter (Millipore Corp.) and degassed with helium for 20 min. The samples were analyzed at a flow rate of 0.5 ml/min and a column pressure of 2800–3000 psi. The elution time of DA was 3–3.5 min. The range of the DA standards was 0–40 nm. The injection volume was 5 μl, and the limit of detection for DA was <0.5 nm. Chromatographic data were collected and processed using a WinChrom Chromatography Data Management System.
Rotating disk electrode measurements of DA uptake. In separate experiments, rotating disk electrode (RDE) voltammetry was used to measure the initial velocity of DA clearance in minced NAc tissue from drug-naive HRs and low LRs. Animals were screened for their response to a novel environment and habituated to the laboratory environment for 4 d to reduce stress on the day of the experiment. Five days after locomotor activity testing, rats were killed by decapitation and brains were rapidly removed. The NAc was dissected as described previously (Thompson et al., 2000; Chefer and Shippenberg, 2002; Zapata and Shippenberg, 2002) to analyze the rate of DA uptake (Meiergerd and Schenk, 1995; Earles and Schenk, 1998). In brief, the NAc tissue was placed in a 1.5 ml microcentrifuge tube and weighed. A total of 500 μl of ice-cold physiological buffer (in nm: 124 NaCl, 3 KCl, 1.24 KH2PO4, 1.3 MgSO4, 2.5 CaCl2, 26 NaHCO3, 10 d-glucose, pH 7.4, gassed with 95% O2–5% CO2 mix) was added to the tissue. The tissue was washed three times by removing and then replacing 400 μl of the buffer. Next, 400 μl of the ice-cold buffer was replaced with room temperature buffer, and the tissue was allowed to incubate at room temperature for 4 min. Then the tissue was removed from the tube, placed on a glass dish, and minced with two scalpel blades. The minced tissue was placed into a Teflon electrochemical cell (with auxiliary and reference electrodes) containing 300 μl of 37°C physiological buffer. The RDE was then lowered into the suspension. The rotation rate of the electrode was set at 4000 rpm, and the suspension was maintained at 37°C and subjected to a constant stream of 95% O2–5% CO2 gas directed over the top of the electrochemical cell.
Voltammetric measurements were made as described previously (Meiergerd and Schenk, 1995; Earles and Schenk, 1998). The applied potential was +450 mV versus Ag/AgCl reference electrode. Data acquisition and analysis were performed using Microcal Origin (Microcal Software Inc., Northampton, MA).
The voltage output was monitored until a relatively stable baseline was obtained (≅15 min), and then 6 μl of one of the known concentrations of DA was added to the suspension (final DA concentrations in solution were 1, 2, 3, 4, 6, 8, and 10 μm). The resultant signals were detected as changes in voltage output from an electrochemical detector (LC 4B; Bioanalytical Systems Inc.) versus time and recorded with a data acquisition system. The initial rate of DA decay after addition of DA, which has been shown to result solely from the DAT-mediated uptake of the DA into the tissue (Povlock and Schenk, 1997), was calculated for a 10 sec interval. The initial decay of the DA signal in the absence of tissue was recorded at the end of each experimental day. The rates of this nonspecific decay were subtracted from the rates observed in the presence of tissue for calculation of the initial clearance rates at each DA concentration. Data were normalized for the tissue weight and expressed as the initial velocity of DA uptake in picomoles per second per gram of wet weight tissue. Values ofKm andVmax were estimated by fitting experimentally obtained values of the initial velocity for each DA concentration to the Michaelis–Menten equation using commercially available software (Graph Pad Prism 3.0; Graph Pad, San Diego, CA). TheVmax/Kmratio, which provides an index of the efficiency of DA clearance (Sabeti et al., 2002), was determined for each group.
[3H](−)-2-β-carbomethoxy-3-β-(4-fluorophenyl)tropane 1,5-naphthale-nedisulfonate binding and DAT Western blots.[3H](−)-2-β-carbomethoxy-3-β-(4-fluorophenyl)tropane 1,5-naphthalenedisulfonate ([3H]WIN35428) binding in synaptosomal preparations was determined as described by Kokoshka et al. (1998). NAc synaptosomes were resuspended in ice-cold 0.32m sucrose in Krebs'-Ringer's bicarbonate buffer, pH 7.4, for [3H]WIN35428 (86 Ci/mmol; PerkinElmer Life Sciences, Emeryville, CA) binding. [3H]WIN35428 binding (2 nm final concentration) was conducted in 0.32m sucrose–Krebs'-Ringer's buffer, pH 7.4, with 50 μg of synaptosomal protein per reaction tube in the presence of different concentrations of unlabeled WIN35428 ranging from 0.1 to 5000 nm. Samples were incubated on ice for 2 hr and then filtered through Whatman GF/B filters (Brandel, Gaithersburg, MD) soaked previously in 0.4% polyethylenimine. Filters were washed rapidly three times with 5 ml of ice-cold phosphate-buffered 0.32 m sucrose, pH 7.4, using a filtering manifold (Brandel). Radioactivity trapped in filters was counted using 5 ml of Bio-Safe II scintillation fluid (Research Products International, Mt. Prospect, IL) added to each tube. IC50 values were determined using one-site competition nonlinear curve fitting (Graph Pad Prism 3.0). The Cheng and Prusoff equation was used to calculate theKd from the IC50.
Immunoblots of DAT were obtained using antiserum B16 (Chemicon, Temecula, CA), generated against rabbit DAT amino acids 42–59 of N terminus. Synaptosomes from NAc were solubilized in SDS-sample loading buffer, and 20–30 μg of protein was electrophoresed on 10% SDS-polyacrylamide gels. After transfer to polyvinylidene difluoride membranes and blocking with 5% nonfat milk, the membranes were probed overnight at 4°C with DAT antibody diluted 1:2000, followed by 1 hr of incubation with goat anti-rabbit HRP-conjugated secondary antibody (1:2000; Cell Signaling Technology, Inc., Beverly, MA). Immunoreactive bands were visualized by ECL on hypersensitive ECL film (Amersham Biosciences, Arlington Heights, IL). Values of DAT protein were normalized by the levels of actin immunoreactivity. The amount of immunoreactive material in each line was quantified using NIH Image 1.61 software.
Data analysis. Microdialysis data are expressed in nanomolar concentrations. The net change in DA (DAin − DAout) was calculated for each animal and then averaged for each perfusion group (DAin: 0, 10, and 40 nm DA). The average net change in DA was plotted against DAin for each time point in each pretreatment group. DAext and Ed were assessed from the linear regression equation as described previously (Parsons et al., 1991a,b). The point at which no DA was gained or lost (DAin − DAout = 0) represents an estimate of DAext concentration. The slope of the linear regression represents the Ed, an indirect measure of DA uptake. The SEM for Ed was assessed directly from regression statistics. The SEM for DAext was calculated using the equation SEMext = [(Sb/b)2 + (Sm/m)2]1/2from Olson and Justice (1993), where SEMext is the SEM for the DAext concentration,Sb is the SD of the y-intercept, b is the y-intercept, Sm is the SD of the Ed, and m is the Ed.
The cocaine-evoked DAext concentration and Ed expressed as a percentage of basal values as well as kinetic parameters for basal DA uptake and the results of [3H]WIN35428 binding were compared between LR and HR animals via unpaired t test with Welch's correction. The behavioral rating score data were converted to area under the curve (AUC) values and subjected to a two-factor ANOVA (pretreatment: cocaine vs saline; response to novelty: LRs vs HRs). The levels of DAext and the Edwere subjected to a two-factor ANOVA (basal vs cocaine-challenge conditions; HRs vs LRs). The accepted value of significance for all tests was p ≤ 0.05. The data are presented as mean ± SEM.
Results
Behavioral sensitization to cocaine in HR and LR animals
Three days after the cessation of the treatment regimens, the acute administration of cocaine (20 mg/kg, i.p.) increased locomotor activity in all experimental groups (HRs and LRs, saline or cocaine pretreatment) (Fig. 1). ANOVA revealed significant main effects of pretreatment (cocaine vs saline:F(1,49) = 47.56; p < 0.01) and individual differences (HRs vs LRs:F(1,49) = 54.25; p < 0.01) on cocaine-evoked locomotor activity. There was a significant pretreatment by individual differences interaction (F(1,49) = 7.52; p < 0.01). Analysis of simple effects showed that there was a significant effect of individual differences in both pretreatment groups (F(1,23) = 14.93, p < 0.01 and F(1,25) = 41.38,p < 0.01 for saline- and cocaine-pretreated animals, respectively), indicating that, regardless of pretreatment, HR rats demonstrated a greater locomotor response to cocaine challenge compared with LRs. However the significant effect of cocaine pretreatment in LR animals (F(1,24) = 7.63;p = 0.011) and HR animals (F(1,24) = 53.4; p < 0.01) showed that sensitization to cocaine develops in both phenotypes.
Characterization of DA dynamics in NAc of HR and LR animals using quantitative microdialysis under transient conditions
Quantitative microdialysis under transient conditions was used to assess basal and drug-evoked DA dynamics in free moving animals. Figure2 shows basal and cocaine-evoked DA dynamics in saline-pretreated LR and HR (Fig. 2A,C) animals 3 d after the cessation of the 5 d treatment regimens. The mean levels of DAext and the Ed for both phenotypes are shown in Figure 2,B and D, respectively. Two-way ANOVA revealed a significant main effect of individual differences (DAext: F(1,19)= 7.49, p = 0.015; Ed:F(1,19) = 428.19, p ≤ 0.01) as well as a significant effect of drug challenge (DAext: F(1,19)= 39.11, p < 0.01; Ed:F(1,19 = 189.19, p < 0.01). A significant individual differences by drug challenge interaction was also seen for both parameters (DAext: F(1,19)= 7.93, p = 0.012; Ed:F(1,19) = 104.93, p < 0.01). Analysis of simple effects revealed a significant effect of cocaine administration on DAext (LRs:F(1,9) = 32.85, p < 0.01; HRs: F(1,9) = 22.59,p < 0.01) and Ed (LRs:F(1,9) = 20,58, p < 0.01; HRs: F(1,9) = 169.64,p < 0.01), indicating that acute cocaine administration significantly increased DAext and decreased DA uptake in saline-pretreated animals, regardless of phenotype. However, there was a significant effect of individual differences on Ed during basal conditions (F(1,9) = 46.85; p < 0.01) and during cocaine challenge (F(1,9) = 573.13; p < 0.01), indicating that DA uptake differed in LR and HR animals during basal conditions as well as during the cocaine challenge. On the other hand, there was a significant effect of individual differences on DAext during cocaine challenge (F(1,9) = 7.77; p = 0.024) but not during basal conditions (F(1,9) = 0.174; p = 0.68), indicating that the concentration of DAextin response to cocaine challenge was significantly higher in HR animals, but basal concentrations of DAext did not differ between groups.
When the same data were expressed as a percentage of basal values (Fig.3) and subjected to unpaired ttests with Welch's correction, both the mean cocaine-evoked decrease in Ed and the increase in DAext were significantly greater in HR compared with LR animals (Ed: p < 0.01,t = 16.68, df = 8; DAext:p = 0.046, t = 2.86, df = 4).
Figure 4 shows basal and cocaine-evoked DA dynamics in LR and HR animals 3 d after cessation of the repeated cocaine treatment regimen. ANOVA revealed a significant main effect of individual differences on Ed(F(1,19) = 67.34; p < 0.01) and DAext(F(1,19) = 15.11; p < 0.01). A significant main effect of acute cocaine administration on the Ed (F(1,19) = 12.82; p < 0.01) and DAext(F(1,19) = 34.19; p < 0.01) as well as a significant individual differences by cocaine interaction (Ed:F(1,19) = 7.43; p = 0.015; DAext:F(1,19) = 11.05; p < 0.01) were also seen. Cocaine administration significantly decreased the Ed in HR rats (F(1,9) = 11.96; p < 0.01) but not LR rats (F(1,9) = 1.08;p = 0.3). In contrast, the acute cocaine challenge significantly increased DAext in both phenotypes (HR: F(1,9) = 22.04, p< 0.01; LR: F(1,9) = 34.62,p < 0.01). These results indicate that acute cocaine administration significantly decreased DA uptake and increased DAext in cocaine-pretreated HR rats, whereas cocaine-pretreated LR rats demonstrated a significant increase in cocaine-evoked DAext but no effect of cocaine challenge on DA uptake. Analysis of simple effects also showed that there was a significant effect of individual differences on both the basal (F(1,9) = 106.92;p < 0.01) and cocaine-evoked (F(1,9) = 32.14; p < 0.01) Ed. Furthermore, although there was a significant effect of individual differences on cocaine-evoked DAext (F(1,9) = 13.1; p < 0.01), no difference between phenotypes in basal DAext was seen (F(1,9) = 3.72; p = 0.09). These data indicate that basal DA uptake and cocaine-induced inhibition of DA uptake were significantly different in cocaine pre-exposed LR and HR rats, while a phenotypic difference in DAext was only apparent during cocaine challenge.
Expression of the same data as a percentage of basal values (Fig.5) revealed that the mean change in Ed after cocaine challenge was significantly greater (Student's t test with Welch's correction:p = 0.032; t = 2.96; df = 5) in HR animals (−20.66 ± 5.81%) than in LR animals (−2.37 ± 2.11%). The mean increase in cocaine-evoked DAext (HR: 367.3 ± 76.8% vs LR: 119.3 ± 20.1%) was also significantly greater (Student's ttest with Welch's correction: p = 0.035;t = 3.13; df = 4) in HRs compared with LRs.
Characterization of basal DA uptake in minced NAc tissue from HR and LR animals using RDE voltammetry
RDE voltammetry was used to characterize the kinetics of DA uptake in the NAc from HR and LR animals (Fig.6). Analysis of the initial velocity of DA uptake showed that the Vmax of uptake was significantly higher (p = 0.048;t = 2.0; df = 74) in HRs (1100 ± 99.8 pmol · sec−1 · gm−1) compared with LRs (874.7 ± 53.4 pmol · sec−1 · gm−1). The Km value for uptake was also significantly greater in HR animals (3.6 vs 1.8 μm; p = 0.040;t = 2.1; df = 74). TheVmax/Kmratio was 0.003 and 0.005 for HRs and LRs, respectively, indicating that the efficiency of basal DA uptake is lower in HRs.
Characterization of DAT function and expression in the NAc of HR and LRs
Individual differences in basal DA uptake and DAext may result from differences in the activity or expression of the DAT in the NAc of HR and LR animals. Western blot assays of DAT protein content were conducted in NAc synaptosomes to determine whether DAT protein expression differed between the two phenotypes. No difference in DAT immunoreactivity was seen (Fig. 7).
Scatchard analysis of [3H]WIN35428 binding to the DAT was conducted in NAc synaptosomes of LR and HR animals. Figure 8 shows that theBmax of [3H]WIN35428 binding was significantly higher in HRs compared with LRs (1340 ± 169 and 821 ± 64 fmol/mg protein, respectively; p < 0.05 by unpairedt test). Analogous, however, to what was observed in uptake studies, the Kd of [3H]WIN35428 binding was also higher in HR compared with LR animals (5.83 ± 0.33 vs 4.19 ± 0.28 nm; Student's t test with Welch's correction; p < 0.05), indicating a lower affinity of DAT in HRs.
Discussion
These studies confirm that the locomotor response to novelty is a reliable predictor of sensitivity to the psychomotor stimulant effects of cocaine (Piazza et al., 1989; Hooks et al., 1991a). Moreover, although all animals that received cocaine repeatedly developed behavioral sensitization, it was more pronounced in HRs than LRs. Microdialysis revealed lower basal DA uptake and a greater cocaine-induced inhibition of uptake in the NAc of drug-naive HRs. Cocaine-evoked increases in DAext were also higher in HRs. Abstinence from repeated cocaine administration decreased basal DA uptake and enhanced cocaine-evoked DAext in both phenotypes. However, HRs exhibited a greater increase in DAext than LRs. TheKm andVmax of DA uptake in the NAc as well as the Kd andBmax values of [3H]WIN35428 binding were also significantly higher in HRs.
Locomotor response to novelty and sensitivity to cocaine
Drug-naive HR rats exhibit greater locomotor activity in response to an acute cocaine challenge than LRs. Three days after the cessation of repeated, context-independent cocaine injections, both HRs and LRs exhibited sensitization to the locomotor activating effects of cocaine. However, the magnitude of sensitization was greater in HRs. These findings are consistent with previous studies (Hooks et al., 1991a). They demonstrate that the response to novelty predicts sensitivity to the behavioral activating effect of acute cocaine and the sensitization that develops after repeated cocaine administration.
Lower basal DA uptake and release in HRs
A previous report (Piazza et al., 1991) showed that the DOPAC/DA ratio, an indirect index of DA release, was higher in NAc homogenates of HRs compared with LRs. In view of the involvement of the mesoaccumbens DA system in novelty as well as the motor and rewarding effects of drugs of abuse, it was hypothesized that enhanced DA neurotransmission underlies the enhanced responsiveness of HR animals. Subsequent microdialysis studies showed that the response to novelty is predictive of individual differences in the responsiveness of the mesoaccumbal DA system to psychostimulants (Hooks et al., 1991b). However, no differences between phenotypes in basal dialysate concentrations of DA were observed. When interpreting both of these findings, however, it is important to note that postmortem analysis of tissue levels of DA and metabolites provides an indirect measure of DA turnover, but actual extracellular levels cannot be determined. In addition, although conventional microdialysis permits assessment of relative changes in neurotransmitter efflux, dialysate neurotransmitter levels are affected by alterations in extracellular levels as well as in uptake. Furthermore, differences in transporter-mediated neurotransmitter reuptake can affect the Ed of the microdialysis probe (Justice, 1993; Smith and Justice, 1994), leading to an underestimation or overestimation of actual extracellular levels.
The no-net-flux method of quantitative microdialysis (Lonn-roth et al., 1987; Parsons and Justice, 1994) provides an estimate of extracellular neurotransmitter concentration that is independent of changes in uptake. Using this technique, Hooks et al. (1992) reported that HRs had higher basal DAext concentration than LRs. Surprisingly, although subsequent studies (Shippenberg and Thompson, 1997; Shippenberg et al., 1999) have shown that differential effects of a particular manipulation on extracellular compared with dialysate levels are caused by differences in Ed, this parameter was unchanged.
The present studies demonstrate that drug-naive HRs had a lowered basal and cocaine-evoked Ed compared with LRs. Furthermore, basal DAext concentration did not differ between groups. Methodological differences may underlie the contrasting results obtained. In contrast to the previous study, in which animals were perfused with several concentrations of DA to quantify DAext, each animal was perfused with only one concentration, preventing potential confounds resulting from insufficient equilibrium time. Second, a randomized and counterbalanced presentation of the various DA concentrations was not used in the previous study. Finally, decreased DA uptake in HRs was also observed using RDE voltammetry, a technique that permits direct assessment of the DA clearance rate in vitro, indicating that the no-net-flux technique used in the present study enabled a valid assessment of basal DA dynamics. Consistent with the present data, DAT knock-down mice, which exhibit decreased DA uptake relative to wild types, showed normal activity in the home cage but were significantly more active than wild types after exposure to a novel environment (Zhuang et al., 2001). Interestingly, unlike the DAT knock-down mice, the lower basal DA uptake in HRs compared with LRs was not accompanied by an elevation of DAext, suggesting that basal DA release is decreased in HRs. Kinetic analysis of DA clearance in RDE studies revealed that both the Km andVmax were higher in HRs. The higherKm is consistent with the decreased basal DA uptake observed in microdialysis experiments.
DAT expression did not differ in the NAc of LR and HR rats. However, these results do not enable differentiation of the cytosolic versus membrane DAT expression. [3H]WIN35428 binding revealed that the affinity of binding is decreased in HRs relative to LRs, but that DAT number is increased. The lower binding affinity in HRs is consistent with the lower affinity of uptake in this phenotype and likely underlies the decreased basal uptake of HRs, whereas an increased number of functionally active DATs and increased maximal capacity of DA clearance in HRs would compensate, at least partially, for the decreased affinity. Under nonchallenged conditions, when synaptic DA concentrations are low, changes in affinity rather than transporter number may be of greater importance in determining uptake rate. However, under challenged conditions, when DA concentrations are high, an increased number of DATs could provide a mechanism for enhanced DA clearance. The question remains as to why the cocaine inhibition of uptake is greater in HRs. Interestingly, a recent study showed that the inhibition of DA uptake by cocaine may result solely from a decrease in the affinity of DA uptake (Wu et al., 2001). Thus, cocaine-evoked increases in Km, coupled with the increased Km for basal uptake in HRs, may underlie the greater response to cocaine in these animals.
Greater cocaine-evoked extracellular DA in HRs
Acute cocaine increases DAext via binding to the DAT and blocking DA uptake into the nerve terminals (Kuhar et al., 1990). Interestingly, it can also abolish dendritic DA release and the resulting autoinhibition of DA neurons (Falkenburger et al., 2001). Although these findings remain controversial because of the ability of cocaine to reduce cell firing, they suggest another possible mechanism that may contribute to the increase in extracellular DA levels in the NAc.
In the present study, acute cocaine challenge increased DAext in all groups. The magnitude of this effect was greater in HRs regardless of whether the data were expressed as absolute values or as the percentage increase from baseline. This finding differs from that of Hooks et al. (1992), who found no difference between phenotypes in percentage increase of DAext after cocaine. One explanation for this discrepancy is that Ed determined during basal conditions was used to calculate DAext after cocaine challenge. As demonstrated by Smith and Justice (1994), uptake is the primary neuronal process affecting Ed. Because cocaine inhibits uptake and decreases the Ed, the use of basal Ed for calculation of cocaine-evoked DAext would lead to an underestimation of actual values. Furthermore, if the magnitude of uptake inhibition by cocaine differed in the two phenotypes, as observed in this study, a confounding of DAextwould occur.
DA dynamics in NAc after chronic cocaine
Basal DA uptake was decreased 3 d after the cessation of cocaine treatment. However, the difference in basal uptake observed in naive HRs and LRs was maintained. Furthermore, although cocaine-evoked DAext was increased at this abstinence time point, the increase was greater in cocaine-treated HRs. In contrast, the decrease in Ed was smaller than in naive HRs (−21 vs −40%), suggesting that the ability of cocaine to inhibit DA cell firing, and thus decrease DA release, may be lessened in HRs pre-exposed to cocaine. Thus, drug-naive HRs and those with a previous cocaine history exhibit diminished basal DA release but enhanced DA release during the cocaine challenge relative to LRs. Moreover, there was no significant effect of cocaine challenge on Ed in cocaine-pretreated LRs (−3% from the baseline). Therefore, we speculate that the increased DAext in these animals is primarily attributable to changes in DA release.
Abstinence from an identical cocaine treatment resulted in reduced basal DA release and enhanced K-evoked DA release as well as DA release observed during a cocaine challenge (Chefer and Shippenberg, 2002). In that study, changes in DA release after cocaine pretreatment could be attributed in part to a subsensitivity of D2autoreceptors in the NAc. Interestingly, D2receptor density is lower in the NAc of HRs compared with LRs (Hooks et al., 1994). Given the documented role of D2receptors in regulation of DA release and DAT function, the altered D2 receptor function may be one mechanism contributing to the differences in DA dynamics observed in these phenotypes.
DA neurotransmission and individual vulnerability to drugs of abuse
Although it is likely that several mechanisms determine vulnerability to the behavioral effects of psychostimulants, our studies highlight the potential role of presynaptic DA neurotransmission in mediating individual differences in responsiveness to cocaine. These studies show that basal DA uptake and release are reduced in individuals that exhibit greater activity in an open field and an enhanced behavioral response to cocaine. The binding affinity of the DAT is also lower in these animals, an effect that is in part compensated for by increased DAT number. The increase in DAext produced by a cocaine challenge is greater in these animals regardless of whether they were drug naive or pre-exposed to cocaine, suggesting that DA release is increased. It was shown recently that lower basal DA release and uptake in the NAc compared with the caudate putamen is associated with greater cocaine-evoked DAext in this region (Wu et al., 2001). This finding and that of the present study indicate an inverse relationship between basal DA dynamics and responsiveness to novelty and cocaine.
Footnotes
This research was supported by the Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health.
Correspondence should be addressed to Dr. T. S. Shippenberg, Integrative Neuroscience Section, Behavioral Neuroscience Branch, National Institute on Drug Abuse/Intramural Research Program, 5500 Nathan Shock Drive, Baltimore, MD 21224. E-mail:tshippen{at}intra.nida.nih.gov.